You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞(01548.HK):傳奇生物擬註冊直接發售546.875萬股ADS,募資3.5億美元

格隆匯5月8日丨金斯瑞生物科技(01548.HK)董事會欣然宣佈,2023年5月5日(美東時間,香港交易時段後),傳奇生物與投資顧問及購買者((由投資顧問建議的基金或賬户)訂立購買協議,據此,傳奇生物同意於註冊直接發售中以每股美國存托股份64美元(相當於約502.4港元)的購買價向購買者發行及出售合共546.875萬股傳奇生物美國存托股份(相當於1093.75萬股傳奇生物股份)。

傳奇生物預計從註冊直接發售中獲得所得款項總額3.5億美元(相當於約27.475億港元)(扣除預計發售費用前)。傳奇生物擬將註冊直接發售所得款項淨額(連同現有現金及現金等價物)用作2025年第四季度前計劃運營開支及資本支出。註冊直接發售預期於2023年5月10日或前後完成,惟須待慣常的完成條件達成。

董事會相信註冊直接發售將同時令公司及傳奇生物集團受益,原因是傳奇生物籌集額外資金投資潛在未來增長及擴張機會以及營運資金需求,將令公司作為傳奇生物的股東而受益。

緊接完成前,傳奇生物由公司非全資擁有約51.36%已發行傳奇生物股份。緊隨註冊直接發售完成後,公司於傳奇生物的股權將被攤薄並下降至49.76%已發行傳奇生物股份(未計及日後配發、發行、行使及歸屬僱員股份擁有權計劃股份,並假設傳奇認股權證未行使)。因此,根據上市規則第14.29條,註冊直接發售構成視作出售公司於傳奇生物的股權。

公吿顯示,投資顧問,T.Rowe Price Associates,Inc.是T.Rowe Price Group,Inc. (納斯達克全球精選市場代碼:TROW)的全資附屬公司。T.Rowe Price Group,Inc.是一家全球投資管理機構,為個人和機構投資者、退休計劃和金融中介提供一系列共同基金、諮詢服務和獨立帳户管理。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account